Clemens Möller joined Boston Consulting Group in 2008. He has deep expertise in large-scale transformation initiatives with global biopharma companies, and is a core member of BCG’s Health Care and People & Organization practices. Clemens leads the firm’s regulatory performance topic and is the global topic expert for biomedical 3-D printing.

Clemens has consulted with leading biopharma research and development organizations on strategy; innovation; operational readiness; process improvement; organizational change; and novel approaches to utilize data and analytics to increase R&D productivity in the digital age.

Prior to joining BCG, he worked on the identification of antiviral drug targets at Pfizer and investigated chronic kidney disease at Massachusetts General Hospital and Harvard Medical School.


  • R&D and innovation
  • Large-scale transformation
  • Data and analytics in health care
  • Additive manufacturing/ 3D-Printing
  • Post-merger integration
  • Operating model/organization design
  • Regulatory performance


  • PhD, summa cum laude, molecular and cell biology, University of Heidelberg
  • Master‘s degree, Ecole Supérieure de Biotechnologie de Strasbourg (ESBS)
Deep Expertise, Broad Experience